menu
    • menu

    Company profile for Allakos

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage company developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases Our lead drug candidate is antolimab (AK002), an investigational antibody that targets Siglec-8, an inhibitory receptor selectively found on mast cells and eosinophils. In clinical and preclinical studies, antolimab has been shown to...
    We are a clinical-stage company developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases Our lead drug candidate is antolimab (AK002), an investigational antibody that targets Siglec-8, an inhibitory receptor selectively found on mast cells and eosinophils. In clinical and preclinical studies, antolimab has been shown to broadly inhibit mast cells and rapidly deplete eosinophils.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AllakosUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    975 Island Drive, Suite 201 Redwood City, CA 94065
    Telephone
    Telephone
    (650) 597-5002
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.allakos.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allakos to be acquired by Concentra Bio for $0.33 in Cash per Share
    Allakos to be acquired by Concentra Bio for $0.33 in Cash per Share

    02 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/02/3054176/0/en/Allakos-Inc-Enters-into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-LLC-for-0-33-in-Cash-per-Share.html

    GLOBENEWSWIRE
    02 Apr 2025
    Share Share
    Allakos axes program, lays off 75% of staff after phase 1 flop
    Allakos axes program, lays off 75% of staff after phase 1 flop

    28 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/allakos-axes-program-lays-75-staff-and-seeks-strategic-alternatives-after-phase-1-flop

    FIERCE BIOTECH
    28 Jan 2025
    Share Share
    Allakos Announces AK006 Trial Results & Company Restructuring
    Allakos Announces AK006 Trial Results & Company Restructuring

    27 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/27/3015460/0/en/Allakos-Announces-Topline-Results-from-its-Phase-1-Trial-of-AK006-in-Patients-with-Chronic-Spontaneous-Urticaria-and-Announces-Restructuring.html

    GLOBENEWSWIRE
    27 Jan 2025
    Share Share
    Allakos Reports Q3 2024 Financials & Provides Business Update
    Allakos Reports Q3 2024 Financials & Provides Business Update

    06 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/06/2976018/0/en/Allakos-Provides-Business-Update-and-Reports-Third-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    06 Nov 2024
    Share Share
    Allakos Announces Ph 1 Trial Results of Subcutaneous AK006
    Allakos Announces Ph 1 Trial Results of Subcutaneous AK006

    10 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/10/2961668/0/en/Allakos-Announces-Phase-1-Trial-Results-of-Subcutaneous-AK006-in-Healthy-Volunteers.html

    GLOBENEWSWIRE
    10 Oct 2024
    Share Share
    Allakos Provides Q2 2024 Financial Results And Business Update
    Allakos Provides Q2 2024 Financial Results And Business Update

    07 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/07/2926316/0/en/Allakos-Provides-Business-Update-and-Reports-Second-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    07 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search